Loading...
•
Jun 30, 2021
Zimmer Biomet Q2 2021 Earnings Report
Reported financial results for the second quarter of 2021.
Key Takeaways
Zimmer Biomet's second quarter net sales were $2.027 billion, an increase of 65.3% over the prior year period, and an increase of 60.7% on a constant currency basis. Second quarter 2021 net sales increased 1.9% when compared to the pre-pandemic second quarter 2019, and were flat on a constant currency basis. Net earnings for the second quarter of 2021 were $141.9 million, or $400.5 million on an adjusted basis. Diluted earnings per share were $0.67 for the second quarter and adjusted diluted earnings per share were $1.90.
Second quarter net sales of $2.027 billion increased 65.3%, 60.7% on a constant currency basis
Second quarter net sales of $2.027 billion increased 65.3%, 60.7% on a constant currency basis
Second quarter diluted earnings per share were $0.67; adjusted diluted earnings per share were $1.90
Company updates 2021 financial guidance, narrowing range for full year outlook
Revenue by Segment
Revenue by Geographic Location
Forward Guidance
The Company is updating its full-year 2021 financial guidance to narrow its previous projected ranges for revenue growth and adjusted diluted EPS:
Positive Outlook
- 2021 reported revenue growth: 14.5% - 16.5%.
- Foreign Currency Exchange Impact: 1.5%
- Adjusted Operating Profit Margin: 26.5% - 27.0%
- Adjusted Tax Rate: 16.0% - 16.5%
- Adjusted Diluted EPS: $7.65 - $7.95
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...